The DOI matches its Crossref record; 45 of the 45 references it cites were found in a registry or an index.
FGF21 Acts Centrally to Induce Sympathetic Nerve Activity, Energy Expenditure, and Weight Loss
Open accessAbstract
The mechanism by which pharmacologic administration of the hormone FGF21 increases energy expenditure to cause weight loss in obese animals is unknown. Here we report that FGF21 acts centrally to exert its effects on energy expenditure and body weight in obese mice. Using tissue-specific knockout mice, we show that βKlotho, the obligate coreceptor for FGF21, is required in the nervous system for these effects. FGF21 stimulates sympathetic nerve activity to brown adipose tissue through a mechanism that depends on the neuropeptide corticotropin-releasing factor. Our findings provide an unexpected mechanistic explanation for the strong pharmacologic effects of FGF21 on energy expenditure and weight loss in obese animals.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Weight loss likely occurs [163,165] at the expense of VAT, as evidenced by a 15% mean decrease in abdominal fat content, measured by DEXA, in obese monkeys [165].”
From The Role of Exercise in the Interplay between Myokines, Hepatokines, Osteokines, Adipokines, and Modulation of Inflammation for Energy Substrate Redistribution and Fat Mass Loss: A Review (2020) · cites this paper as [163]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“FGF21 further augments BAT function indirectly, by increasing SNS output [163,165] (7)”
In the citing paper
“These effects of extended FGF21 signalling in promoting weight loss through increased energy expenditure are mediated through direct actions on the central nervous system67,80–84, not adipose tissues65,67,85”
From Metabolic messengers: FGF21 (2021) · cites this paper as [80]
In the citing paper
“Instead, FGF21 signals directly to the CNS (Fig. 3a), at least in rodents, and consequently regulates energy expenditure and improves glucose and lipid homeostasis80,82.”
From Metabolic messengers: FGF21 (2021) · cites this paper as [80]
In the citing paper
“while it signals the CNS to increase energy expenditure and decrease body weight [169,171,172] (Figure 2).”
From Hepatokines and metabolism: Deciphering communication from the liver (2021) · cites this paper as [172]
In the citing paper
“The chronic metabolic effects of FGF21 on body weight and glucose homeostasis are lost when β-klotho is deleted from the CNS (Klbfl/fl;Camk2a-Cre) (101, 126).”
From Fibroblast Growth Factor 21: A Versatile Regulator of Metabolic Homeostasis (2018) · cites this paper as [101]
In the citing paper
“FGF21 administration increases sympathetic nerve activity to BAT (101) and WAT (28), and browning of WAT depots (28, 101).”
From Fibroblast Growth Factor 21: A Versatile Regulator of Metabolic Homeostasis (2018) · cites this paper as [101]
In the citing paper
“The administration of a corticotropin-releasing hormone antagonist blocks FGF21-mediated increases in sympathetic nerve activity to BAT (101).”
From Fibroblast Growth Factor 21: A Versatile Regulator of Metabolic Homeostasis (2018) · cites this paper as [101]
In the citing paper
“Interestingly, FGF21-mediated increases in sympathetic nerve activity to BAT appear to require hypothalamic corticotropin-releasing hormone.”
From Fibroblast Growth Factor 21: A Versatile Regulator of Metabolic Homeostasis (2018) · cites this paper as [101]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Brown Adipose Tissue: Function and Physiological Significance
CANNON, B., & NEDERGAARD, J. (2004) · Physiological Reviews · doi:10.1152/physrev.00015.2003 · Cited by 6,433
FGF-21 as a novel metabolic regulator
Kharitonenkov, A., Shiyanova, T. L., Koester, A., Ford, A. M., Micanovic, R., Galbreath, E. J., Sandusky, G. E., Hammond, L. J., Moyers, J. S., Owens, R. A., et al. (2005) · Journal of Clinical Investigation · doi:10.1172/jci23606 · Cited by 2,125
FGF21 regulates PGC-1α and browning of white adipose tissues in adaptive thermogenesis
Fisher, F. M., Kleiner, S., Douris, N., Fox, E. C., Mepani, R. J., Verdeguer, F., Wu, J., Kharitonenkov, A., Flier, J. S., Maratos-Flier, E., et al. (2012) · Genes & Development · doi:10.1101/gad.177857.111 · Cited by 1,478 · cited 8×
“FGF21 also promotes the browning of scWAT (Fisher et al., 2012), an effect that in vivo involves bKlotho in the nervous system.”
InfluentialXu, J., Lloyd, D. J., Hale, C., Stanislaus, S., Chen, M., Sivits, G., Vonderfecht, S., Hecht, R., Li, Y.-S., Lindberg, R. A., et al. (2009) · Diabetes · doi:10.2337/db08-0392 · Cited by 1,151
Fibroblast Growth Factor 21 Corrects Obesity in Mice
Coskun, T., Bina, H. A., Schneider, M. A., Dunbar, J. D., Hu, C. C., Chen, Y., Moller, D. E., & Kharitonenkov, A. (2008) · Endocrinology · doi:10.1210/en.2008-0816 · Cited by 1,031
The effects of LY2405319, an FGF21 analog, in obese human subjects with type 2 diabetes
Gaich, G., Chien, J. Y., Fu, H., Glass, L. C., Deeg, M. A., Holland, W. L., Kharitonenkov, A., Bumol, T., Schilske, H. K., & Moller, D. E. (2013) · Cell Metabolism · doi:10.1016/j.cmet.2013.08.005 · Cited by 885
The metabolic state of diabetic monkeys is regulated by fibroblast growth factor-21
Kharitonenkov, A., Wroblewski, V. J., Koester, A., Chen, Y.-F., Clutinger, C. K., Tigno, X. T., Hansen, B. C., Shanafelt, A. B., & Etgen, G. J. (2007) · Endocrinology · doi:10.1210/en.2006-1168 · Cited by 738
Fon Tacer, K., Bookout, A. L., Ding, X., Kurosu, H., John, G. B., Wang, L., Goetz, R., Mohammadi, M., Kuro-o, M., Mangelsdorf, D. J., et al. (2010) · Molecular Endocrinology · doi:10.1210/me.2010-0142 · Cited by 700
Self-citationLin, Z., Tian, H., Lam, K. S. L., Lin, S., Hoo, R. C. L., Konishi, M., Itoh, N., Wang, Y., Bornstein, S. R., Xu, A., et al. (2013) · Cell Metabolism · doi:10.1016/j.cmet.2013.04.005 · Cited by 691
BMP8B Increases Brown Adipose Tissue Thermogenesis through Both Central and Peripheral Actions
Whittle, A. J., Carobbio, S., Martins, L., Slawik, M., Hondares, E., Vázquez, M. J., Morgan, D., Csikasz, R. I., Gallego, R., Rodriguez-Cuenca, S., et al. (2012) · Cell · doi:10.1016/j.cell.2012.02.066 · Cited by 573
Self-citation
Flagged first, then by citations
Cited by
Sorted by citations
Items 301–400 of 519
Transcriptional control and hormonal response of thermogenic fat
Emont, M. P., Yu, H. M., & Wu, J. (2015) · Journal of Endocrinology · doi:10.1530/joe-15-0026 · Cited by 19
Fibroblast growth factor 21: update on genetics and molecular biology
Barros, D. R., & Hegele, R. A. (2024) · Current Opinion in Lipidology · doi:10.1097/mol.0000000000000960 · Cited by 18
Anterograde regulation of mitochondrial genes and FGF21 signaling by hepatic LSD1
Cao, Y., Tang, L., Du, K., Paraiso, K. D., Sun, Q., Liu, Z., Ye, X., Fang, Y., Yuan, F., Chen, H., et al. (2021) · JCI Insight · doi:10.1172/jci.insight.147692 · Cited by 20
The autonomic nervous system in the regulation of glucose and lipid metabolism
Wangler, S., Jarczok, M. N., Ennis, M., Herhaus, B., Wagner, R., Sehgal, R., & Heni, M. (2026) · Nature Reviews Endocrinology · doi:10.1038/s41574-025-01221-w · Cited by 17
Vernia, S., Lee, A., Kennedy, N. J., Han, M. S., Isasa, M., Cavanagh, J., Roy, A., Syed, A., Chaudhry, S., Edwards, Y. J. K., et al. (2022) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2210434119 · Cited by 17
Fibroblast Growth Factor 21-Null Mice Do Not Exhibit an Impaired Response to Fasting
Antonellis, P. J., Hayes, M. P., & Adams, A. C. (2016) · Frontiers in Endocrinology · doi:10.3389/fendo.2016.00077 · Cited by 17
Fletcher, J. A., Linden, M. A., Sheldon, R. D., Meers, G. M.-E., Morris, E. M., Butterfield, A. M., Perfield, J. W., Rector, R. S., & Thyfault, J. P. (2017) · Experimental Physiology · doi:10.1113/ep086629 · Cited by 17
Moro, J., Chaumontet, C., Even, P. C., Blais, A., Piedcoq, J., Gaudichon, C., Tomé, D., & Azzout‐Marniche, D. (2021) · Scientific Reports · doi:10.1038/s41598-021-91274-4 · Cited by 17
Fibroblast growth factor 21 in dairy cows: current knowledge and potential relevance
Eder, K., Geßner, D. K., & Ringseis, R. (2021) · Journal of Animal Science and Biotechnology/Journal of animal science and biotechnology · doi:10.1186/s40104-021-00621-y · Cited by 18
Schlessinger, K., Li, W., Tan, Y., Liu, F., Souza, S. C., Tozzo, E., Liu, K., Thompson, J. R., Wang, L., & Muise, E. S. (2015) · Obesity · doi:10.1002/oby.21153 · Cited by 17
Soundarrajan, M., Deng, J., Kwasny, M., Rubert, N. C., Nelson, P. C., Abou-el-Seoud, D., Landsberg, L., & Neff, L. M. (2020) · Adipocyte · doi:10.1080/21623945.2020.1724740 · Cited by 20
Hope, D. C. D., & Tan, T. M.-M. (2023) · Peptides · doi:10.1016/j.peptides.2023.170962 · Cited by 16
Martins, I. P., Vargas, R., Saavedra, L. P. J., Rickli, S., Matiusso, C. C. I., Pavanello, A., Casagrande, L., Pastre, M. J., Oliveira, J. B., de Almeida, A. M., et al. (2022) · Nutrition · doi:10.1016/j.nut.2022.111945 · Cited by 16
Geroprotective interventions in the 3xTg mouse model of Alzheimer’s disease
Sonsalla, M. M., & Lamming, D. W. (2023) · GeroScience · doi:10.1007/s11357-023-00782-w · Cited by 17
Liu, Z., Wei, S., Jiang, Y. Z., Su, W., Ma, F., Cai, G., Liu, Y., Sun, X., Lu, L., Fu, W., et al. (2025) · Journal of Hepatology · doi:10.1016/j.jhep.2025.02.003 · Cited by 15
Satoh, A., Han, S., Araki, M., Nakagawa, Y., Ohno, H., Mizunoe, Y., Kumagai, K., Murayama, Y., Osaki, Y., IWASAKI, H. O., et al. (2020) · iScience · doi:10.1016/j.isci.2020.100930 · Cited by 15
Caffeine suppresses high-fat diet-induced body weight gain in mice depending on feeding timing
Haraguchi, A., Yamazaki, T., Ryan, C., Ito, K., Sato, S., Tamura, K., Sekiguchi, M., Cao, S., & Shibata, S. (2022) · Journal of Functional Foods · doi:10.1016/j.jff.2022.105307 · Cited by 15
Wang, X., Li, Y., Qiang, G., Wang, K., Dai, J., McCann, M. A., Munoz, M. D., Gil, V., Yu, Y., Li, S., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-34259-9 · Cited by 15
Role of the Adipocyte in Metabolism and Endocrine Function
Ravussin, É., & Smith, S. R. (2015) · Elsevier eBooks · doi:10.1016/b978-0-323-18907-1.00036-6 · Cited by 16
Liu, H., Hu, Y. C., French, S. W., Gonzalez, F. J., & Wan, Y. Y. (2015) · Oncotarget · doi:10.18632/oncotarget.3531 · Cited by 15
Energy metabolism: An emerging therapeutic frontier in liver fibrosis
Irshad, I., Alqahtani, S. A., Ikejima, K., Yu, M., Romero‐Gómez, M., & Eslam, M. (2025) · Annals of Hepatology · doi:10.1016/j.aohep.2025.101896 · Cited by 14
Brain-acting hepatokines: its impact on energy balance and metabolism
Giovanini, L., Wanionok, N. E., Perelló, M., & Cornejo, M. P. (2025) · Frontiers in Neuroscience · doi:10.3389/fnins.2025.1589110 · Cited by 15
FGF21 mediating the Sex-dependent Response to Dietary Macronutrients
Sauza, K. A. S., & Ryan, K. K. (2024) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgae363 · Cited by 14
Exploring endocrine FGFs - structures, functions and biomedical applications
Phan, P. (2024) · International Journal of Biochemistry and Molecular Biology · doi:10.62347/palk2137 · Cited by 16
Zapata, R. C., Singh, A., Pezeshki, A., & Chelikani, P. K. (2018) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2018.12.006 · Cited by 14
Genome-wide association study for circulating fibroblast growth factor 21 and 23
Chuang, G., Liu, P., Chyan, T., Huang, C.-H., Huang, Y., Lin, C.-H., Lin, J., Hsu, C., Tsai, R., Hsieh, M.-L., et al. (2020) · Scientific Reports · doi:10.1038/s41598-020-71569-8 · Cited by 14
Molecular and cellular regulation of thermogenic fat
Wang, C., Wang, X., & Hu, W. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1215772 · Cited by 14
Role of adipokines FGF21, leptin and adiponectin in self-concept of youths with obesity
Li, G., Feng, D., Qu, X., Fu, J., Wang, Y., Li, L., Li, L., Han, L., Esangbedo, I. C., Li, M., et al. (2018) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2018.05.015 · Cited by 14
Trefts, E., Hughey, C. C., Lantier, L., Lark, D. S., Boyd, K. L., Pozzi, A., Zent, R., & Wasserman, D. H. (2019) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00496.2018 · Cited by 14
The Role of Kupffer Cells as Mediators of Adipose Tissue Lipolysis
Ma, W., Zhao, D., He, F., & Tang, L. (2019) · The Journal of Immunology · doi:10.4049/jimmunol.1900366 · Cited by 14
Reyes, J., Zhao, Y., Pandya, K., & Yap, G. S. (2023) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2023.11.029 · Cited by 13
Ji, Y. R., Duan, Y., Li, Y., Lu, Q., Liu, D., Yang, Y., Chang, R., Jing, T., Yao, W., Yin, J., et al. (2024) · British Journal of Pharmacology · doi:10.1111/bph.16378 · Cited by 14
Meroni, M., Dongiovanni, P., Tiano, F., Piciotti, R., Alisi, A., & Panera, N. (2024) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2024.117608 · Cited by 13
Laker, R. C., Egolf, S., Will, S., Lantier, L., McGuinness, O. P., Brown, C. L., Bhagroo, N. V., Oldham, S. N., Kuszpit, K. K., Alfaro, A., et al. (2025) · Nature Communications · doi:10.1038/s41467-025-59773-4 · Cited by 15
An, H. J., Lee, B., Kim, D. H., Lee, E. K., Chung, K. W., Park, M. H., Jeong, H. O., Kim, S. M., Moon, K. M., Kim, Y. R., et al. (2017) · Oncotarget · doi:10.18632/oncotarget.14818 · Cited by 13
Dorval, L., Knapp, B. I., Majekodunmi, O. A., Eliseeva, S. I., & Bidlack, J. M. (2021) · Neuropharmacology · doi:10.1016/j.neuropharm.2021.108858 · Cited by 13
AAV‐mediated gene therapy as a strategy to fight obesity and metabolic diseases
Sponton, C. H., & Kajimura, S. (2018) · EMBO Molecular Medicine · doi:10.15252/emmm.201809431 · Cited by 13
Lee, S. Y., Burns, S. F., NG, K. K. C., Stensel, D. J., Zhong, L., Tan, F. H. Y., Chia, K. L., Fam, K. D., Yap, M. M. C., Yeo, K. P., et al. (2019) · Medicine & Science in Sports & Exercise · doi:10.1249/mss.0000000000002150 · Cited by 13
Usui, N., Yoshida, M., Takayanagi, Y., Nasanbuyan, N., Inutsuka, A., Kurosu, H., Mizukami, H., Mori, Y., Kuro‐o, M., & Onaka, T. (2021) · Journal of Neuroendocrinology · doi:10.1111/jne.13026 · Cited by 13
Murray, S. A., Dalbøge, L. S., Baquero, K., Sanford, C. A., Misquith, A., Mercer, A. J., Meek, T. H., Guldbrandt, M., Andersen, B., Kievit, P., et al. (2020) · Scientific Reports · doi:10.1038/s41598-020-64170-6 · Cited by 12
Long-term effects of a fat-directed FGF21 gene therapy in aged female mice
Anderson, J. M., Arnold, W. D., Huang, W., Ray, A., Owendoff, G., & Cao, L. (2023) · Gene Therapy · doi:10.1038/s41434-023-00422-0 · Cited by 13
Protein Restriction in Metabolic Health: Lessons from Rodent Models
Na, K., & Park, Y. J. (2024) · Nutrients · doi:10.3390/nu16020229 · Cited by 12
Imbalanced Skeletal Muscle Mitochondrial Proteostasis Causes Bone Loss
Jin, Z., Mao, Y., Guo, Q., Yin, Y., Kiram, A., Zhou, D., Yang, J., Zhou, Z., Xue, J., Feng, Z., et al. (2024) · Research · doi:10.34133/research.0465 · Cited by 13
Advances in FGFs for diabetes care applications
Liu, Y., Chen, Q., Li, Y., Bi, L., He, Z., Shao, C., Jin, L., Peng, R., & Zhang, X. (2022) · Life Sciences · doi:10.1016/j.lfs.2022.121015 · Cited by 12
Tada, A., Misawa, E., Tanaka, M., Saito, M., Nabeshima, K., Yamauchi, K., Abe, F., Goto, T., & Kawada, T. (2020) · Journal of Nutritional Science and Vitaminology · doi:10.3177/jnsv.66.176 · Cited by 12
Esteve, N. A., Rogers, D. J., Stagray, J. A., Mayeux, H., Nora, G., Huval, L., & Smith, K. M. (2024) · European Journal of Neuroscience · doi:10.1111/ejn.16473 · Cited by 11
Characterization of FGF21 Sites of Production and Signaling in Mice
Sullivan, A. I., Jensen-Cody, S. O., Claflin, K. E., Vorhies, K., Flippo, K. H., & Potthoff, M. J. (2024) · Endocrinology · doi:10.1210/endocr/bqae120 · Cited by 11
Activating Connexin43 gap junctions primes adipose tissue for therapeutic intervention
Zhu, Y., Li, N., Huang, M., Chen, X., An, Y., Li, J., Zhao, S., Funcke, J., Cao, J., He, Z., et al. (2022) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2022.02.020 · Cited by 12
Contribution of organokines in the development of NAFLD/NASH associated hepatocellular carcinoma
Vachher, M., Bansal, S., Kumar, B., Yadav, S., Arora, T. K., Wali, N. M., & Burman, A. (2022) · Journal of Cellular Biochemistry · doi:10.1002/jcb.30252 · Cited by 11
Focus on Alzheimer’s Disease: The Role of Fibroblast Growth Factor 21 and Autophagy
Yang, L., & Nao, J. (2022) · Neuroscience · doi:10.1016/j.neuroscience.2022.11.003 · Cited by 11
Corbee, R. J., van Everdingen, D. L., Kooistra, H. S., & Penning, L. C. (2023) · Frontiers in Veterinary Science · doi:10.3389/fvets.2022.1086987 · Cited by 11
Endocrine FGFs and their signaling in the brain: Relevance for energy homeostasis
Zangerolamo, L., Carvalho, M. U. W. B. D., Velloso, L. A., & Barbosa, H. C. L. (2023) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2023.176248 · Cited by 11
Huai, Q., Zhu, C., Zhang, X., Dai, H., Li, X., & Wang, H. (2024) · Hepatology Communications · doi:10.1097/hc9.0000000000000410 · Cited by 11
Reduced adiposity attenuates FGF21 mediated metabolic improvements in the Siberian hamster
Lewis, J. E., Samms, R. J., Cooper, S., Luckett, J., Perkins, A. C., Adams, A. C., Tsintzas, K., & Ebling, F. J. P. (2017) · Scientific Reports · doi:10.1038/s41598-017-03607-x · Cited by 11
Research progress on the role of FGF21 in insulin resistance
Zhang, H., Zhu, R., Sun, Q., & Du, L. (2025) · Frontiers in Endocrinology · doi:10.3389/fendo.2025.1619462 · Cited by 10
Uncoupling Protein-1 Modulates Anxiety-Like Behavior in a Temperature-Dependent Manner
Sideromenos, S., Gundacker, A., Nikou, M., Oberle, R., Horváth, O., Stöhrmann, P., Partonen, T., & Pollak, D. D. (2022) · Journal of Neuroscience · doi:10.1523/jneurosci.2509-21.2022 · Cited by 11
Ruocco, C., Malavazos, A. E., Ragni, M., Carruba, M. O., Valerio, A., Iacobellis, G., & Nisoli, E. (2023) · Pharmacological Research · doi:10.1016/j.phrs.2023.106892 · Cited by 10
Mitochondrial quality orchestrates muscle-adipose dialog to alleviate dietary obesity
Xu, Z., Fu, T., Guo, Q., Sun, W., & Gan, Z. (2018) · Pharmacological Research · doi:10.1016/j.phrs.2018.12.020 · Cited by 10
En, M., Yakovleva, T. V., Balybina, N., Baranov, K. O., Denisova, E. I., Dubinina, A., Feofanova, N. A., & Бажан, Н. М. (2020) · Vavilov Journal of Genetics and Breeding · doi:10.18699/vj20.40-o · Cited by 10
FGF21 negatively affects long-term female fertility in mice
Moeckli, B., Pham, T.-V., Slits, F., Latrille, S., Peloso, A., Delaune, V., Oldani, G., Lacotte, S., & Toso, C. (2022) · Heliyon · doi:10.1016/j.heliyon.2022.e11490 · Cited by 9
Bonet, M. L., Ribot, J., Sánchez, J., Palou, A., & Picó, C. (2024) · Cells · doi:10.3390/cells13100870 · Cited by 10
Andrés-Hernando, A., Orlicky, D. J., García, G., Loetz, E. C., Montoya, R., Kumar, V., Effinger, D. P., Kuwabara, M., Bae, S., Lorenzo-Rebenaque, L., et al. (2025) · Nature Metabolism · doi:10.1038/s42255-025-01402-x · Cited by 9
Bibliometric analysis of fibroblast growth factor 21 research over the period 2000 to 2021
She, Q.-Y., Li, L., Liu, M.-H., Tan, R.-Y., Zhong, Y.-W., Bao, J., & Xie, J.-D. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.1011008 · Cited by 9
Insights into energy balance dysregulation from a mouse model of methylmalonic aciduria
Lucienne, M., Gerlini, R., Rathkolb, B., Calzada‐Wack, J., Forny, P., Wueest, S., Kaech, A., Traversi, F., Forny, M., Bürer, C., et al. (2023) · Human Molecular Genetics · doi:10.1093/hmg/ddad100 · Cited by 9
Yu, W., Zhu, H., Chen, X., Gu, X., Zhang, X., Shen, F., Jia, W., & Hu, C. (2019) · Journal of Diabetes Research · doi:10.1155/2019/9387358 · Cited by 9
Бажан, Н. М., Jakovleva, T., Kazantseva, A. Y., Костина, Н. Е., Orlov, P. E., Balybina, N., Baranov, K. O., & En, M. (2023) · Vavilov Journal of Genetics and Breeding · doi:10.18699/vjgb-23-40 · Cited by 9
Calubag, M. F., Ademi, I., Grunow, I., Breuer, L., Babygirija, R., Lialios, P., Le, S. M., Minton, D. M., Sonsalla, M. M., Illiano, J., et al. (2025) · Aging Cell · doi:10.1111/acel.70176 · Cited by 9
Engelbeen, S., Jacobsen, J. M., Deisen, L., Parsche, E., Buch-Rasmussen, A. S., Clemmensen, C., Kuhre, R. E., Johann, K., & Kleinert, M. (2025) · The FASEB Journal · doi:10.1096/fj.202501350r · Cited by 8
Lifelong restriction of dietary valine has sex-specific benefits for health and lifespan in mice
Calubag, M. F., Ademi, I., Green, C. L., Manchanayake, D. N. H., Jayarathne, H. S. M., Marshall, R. N., Le, S. M., Lialios, P., Breuer, L. E., Yakar, S., et al. (2026) · Nature Aging · doi:10.1038/s43587-026-01169-0 · Cited by 9
Fibroblast growth factor 21 and dietary interventions: what we know and what we need to know next
Jin, T. (2022) · Medical Review · doi:10.1515/mr-2022-0019 · Cited by 8
Inter-Organ Communication Involved in Brown Adipose Tissue Thermogenesis
Takahashi, K., Yamada, T., & Katagiri, H. (2024) · Advances in experimental medicine and biology · doi:10.1007/978-981-97-4584-5_11 · Cited by 8
Molecular epigenetics in the transition of white to brown fat
Chaturvedi, S., Chaturvedi, P., Gupta, P. C., Awasthi, S. K., & Kalani, A. (2025) · Pathology - Research and Practice · doi:10.1016/j.prp.2025.156073 · Cited by 8
Guerra, N. P., Parveen, A., Bühler, D., Brauer, D., Müller, L., Pilz, K., Witt, M., Glass, A. S., Bajorat, R., Janowitz, D., et al. (2021) · Nutrients · doi:10.3390/nu13092916 · Cited by 8
Regulatory networks determining substrate utilization in brown adipocytes
Onogi, Y., & Ussar, S. (2022) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2022.04.001 · Cited by 8
Pálsdóttir, V., Windahl, S. H., Hägg, D. A., Keantar, H., Bellman, J., Buchanan, A. G., Vaughan, T. J., Lindén, D., Jansson, J., & Ohlsson, C. (2019) · Endocrinology · doi:10.1210/en.2018-01002 · Cited by 8
Omileke, F., Ishiwata, S., Matsuo, J., Yoshida, F., Hidese, S., Hattori, K., & Kunugi, H. (2020) · Neuropsychopharmacology Reports · doi:10.1002/npr2.12102 · Cited by 8
Geidl, B., Hochuli, M., Spinas, G. A., & Gerber, P. A. (2022) · Nutrients · doi:10.3390/nu14194169 · Cited by 9
Koh, Y. J., Lee, J., & Park, S. Y. (2018) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2018/4737515 · Cited by 8
Khayari, A. E., Hakam, S. M., Malka, G., Rochette, L., & Fatimy, R. E. (2023) · Genes & Diseases · doi:10.1016/j.gendis.2023.101174 · Cited by 7
Imeglimin modulates mitochondria biology and facilitates mitokine secretion in 3T3-L1 adipocytes
Takahashi, N., Kimura, A. P., Yoshizaki, T., & Ohmura, K. (2024) · Life Sciences · doi:10.1016/j.lfs.2024.122735 · Cited by 7
Handzlik‐Orlik, G., Owczarek, A. J., Więcek, A., Mossakowska, M., Zdrojewski, T. R., Chudek, A., Olszanecka‐Glinianowicz, M., & Chudek, J. T. (2024) · Aging · doi:10.18632/aging.206114 · Cited by 7
Sostre‐Colón, J., Gavin, M. J., Santoleri, D., & Titchenell, P. M. (2022) · Endocrinology · doi:10.1210/endocr/bqac035 · Cited by 7
Research Progress of Fibroblast Growth Factor 21 in Fibrotic Diseases
Jia, M.-Q., Guan, C., Tao, J., & Zhou, Y. (2022) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2022/5042762 · Cited by 7
Hepatic protein kinase Cbeta deficiency mitigates late-onset obesity
Shu, Y., Gumma, N., Hassan, F., Branch, D. A., Baer, L. A., Ostrowski, M. C., Stanford, K. I., Baskin, K. K., & Mehta, K. D. (2023) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2023.104917 · Cited by 7
Fibroblast growth factor 21 ameliorates cholestatic liver injury via a hepatic FGFR4-JNK pathway
Zhou, C., Pan, X., Huang, L., Wu, T., Zhao, T., Qi, J., Wu, J., Mukondiwa, A. V., Tang, Y., Luo, Y., et al. (2023) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2023.166870 · Cited by 7
α1-Adrenergic receptor downregulates hepatic FGF21 production and circulating FGF21 levels in mice
Nonogaki, K., & Kaji, T. (2016) · Neuroscience Letters · doi:10.1016/j.neulet.2016.12.008 · Cited by 7
Maternal obesity impairs fetal brown adipogenesis by attenuating fetal FGF21 signaling
Hua, L., Shen, W., Gao, D., Yang, Y., Yang, X., Zhang, H., Liu, S., Liu, L., Cao, Y., Jiang, X., et al. (2025) · Cell Reports · doi:10.1016/j.celrep.2025.115935 · Cited by 8
Loomba, R. S., George, J., Castéra, L., Francque, S., Lawitz, E., Shoeb, A., Clausen, J. O., Andersen, B., Larsen, A. B., & Gluud, L. L. (2026) · The Lancet. Gastroenterology & hepatology · doi:10.1016/s2468-1253(26)00123-8 · Cited by 7
Double promoter and tandem gene strategy for efficiently expressing recombinant FGF21
Liu, L., Ning, N., Xu, S., Chen, D., Zhou, L., Guo, Z., Liang, X., & Ye, X. (2024) · Microbial Cell Factories · doi:10.1186/s12934-024-02447-5 · Cited by 6
Treating metabolic dysfunction‐associated steatohepatitis: The fat‐trimming FGF21 approach
Li, X., Rao, Z., Hu, W., Lu, W., & Luo, Y. (2024) · Obesity Reviews · doi:10.1111/obr.13861 · Cited by 6
In Pursuit of a Biomarker of Weight Gain Susceptibility—Is FGF21 a Candidate?
Redman, L. M., & Ravussin, É. (2019) · Diabetes · doi:10.2337/dbi18-0038 · Cited by 6
New insights and advances of sodium-glucose cotransporter 2 inhibitors in heart failure
Li, J., Zhou, L., & Gong, H. (2022) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2022.903902 · Cited by 6
MAPL loss dysregulates bile and liver metabolism in mice
Goyon, V., Besse‐Patin, A., Zunino, R., Ignatenko, O., Nguyen, M., Coyaud, É., Lee, J. M., Nguyen, B., Raught, B., & McBride, H. M. (2023) · EMBO Reports · doi:10.15252/embr.202357972 · Cited by 6
Rajan, S., Mandikian, D., Baruch, A., Gelzleichter, T. R., Stevens, D. W., Sonoda, J., Cowan, K. J., Boswell, C. A., & Stefanich, E. G. (2017) · mAbs · doi:10.1080/19420862.2017.1373923 · Cited by 6
Rang, Y., Ma, S., Yang, J., Liu, H., Suzuki, K., & Liu, C. (2021) · Metabolites · doi:10.3390/metabo11050301 · Cited by 7
Gehring, J., Azzout‐Marniche, D., Chaumontet, C., Piedcoq, J., Gaudichon, C., & Even, P. C. (2021) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00246.2021 · Cited by 7
The role of FGF21 in the metabolic adjustments required for exercise capacity
Abe, L., & Dantzer, R. (2025) · Life Sciences · doi:10.1016/j.lfs.2025.123940 · Cited by 5
Boisclair, Y. R., & Giesy, S. L. (2024) · Journal of Dairy Science · doi:10.3168/jds.2024-25799 · Cited by 5
Alamgir, M., Sohal, A., & Kowdley, K. V. (2026) · Drug Design Development and Therapy · doi:10.2147/dddt.s560039 · Cited by 5
Context matters for addressing controversies in FGF21 biology
Wu, C.-T., & Ryan, K. K. (2024) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2024.02.013 · Cited by 5
Metadata
- Authors
- Owen, B. M., Ding, X., Morgan, D. A., Coate, K. C., Bookout, A. L., Rahmouni, K., Kliewer, S. A., & Mangelsdorf, D. J.
- Affiliations
- The University of Texas Southwestern Medical Center (US)
- University of Iowa (US)
- Howard Hughes Medical Institute (US)
- Corresponding author
- Kliewer, Steven A.
- Mangelsdorf, David J.
- ORCID
- Venue
- Cell Metabolism
- Publisher
- Elsevier BV
- Published
- 2014-10
- Volume
- 20
- Issue
- 4
- Pages
- 670-677
- ISSN
- 1550-4131 (ISSN-L)
- PMC
- PMC4192037
- OpenAlex
- W2158477352
- Cited by
- 523
- References
- 45
- Citations by year
- 2026: 35 · 2025: 39 · 2024: 40 · 2023: 43 · 2022: 49 · 2021: 38 · 2020: 49 · 2019: 46 · 2018: 50 · 2017: 44 · 2016: 39 · 2015: 47 · 2014: 3
- FWCI
- 18.17
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- Locations
- Cell Metabolism (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Institutes of Health (1F32DK098908, GM007062, HL084207, R01DK067158)
- Howard Hughes Medical Institute
- Welch Foundation (I-1275, I-1558)
- American Heart Association (14EIA18860041)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Fibroblast Growth Factor Research
- Life Sciences › Neuroscience › Endocrine and Autonomic Systems › Regulation of Appetite and Obesity
- Health Sciences › Medicine › Physiology (medical) › Adipose Tissue and Metabolism
- Keywords
- FGF21, β-Klotho, central nervous system, sympathetic activity, brown adipose tissue, energy expenditure, weight loss, corticotropin-releasing factor, obesity, tissue-specific knockout mice
- MeSH terms
- Klotho Proteins, Animals, Adipose Tissue, Brown, Corticotropin-Releasing Hormone, Energy Metabolism, Fibroblast Growth Factors, Hypothalamus, Membrane Proteins, Mice, Inbred C57BL, Mice, Obese, Mice, Transgenic, RNA, Messenger, Sympathetic Nervous System, Weight Loss, Mice, Knockout, Thermogenesis, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
